LON:ARIX Arix Bioscience (ARIX) Share Price, News & Analysis → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free ARIX Stock Alerts GBX 142 0.00 (0.00%) (As of 02/12/2024) Add Compare Share Share Today's Range 142▼ 14250-Day Range 142▼ 14252-Week Range 97▼ 145Volume377,046 shsAverage Volume636,934 shsMarket Capitalization£183.73 millionP/E Ratio1,290.91Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesInsider TradesStock AnalysisChartHeadlinesInsider Trades Get Arix Bioscience alerts: Email Address Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy About Arix Bioscience Stock (LON:ARIX)Arix Bioscience plc is a venture capital firm specializing in all stages of growth, seed stage, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity. The firm seeks to invest in biotech companies, novel therapeutics, innovative technologies, medical innovation comprising healthcare and life sciences. It seeks to invest globally. The firm employs an evergreen approach to funding. It primarily makes investments from its own balance sheet. The firm prefers to take board seat. The firm exit when the optimum value has been reached. Arix Bioscience plc is formerly known as Perceptive Bioscience Investments Limited. Arix Bioscience plc was founded in 2015 and is based in London, United Kingdom.Read More ARIX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ARIX Stock News HeadlinesApril 17, 2024 | finance.yahoo.comSphere Fluidics Appoints Edward Rayner as Non-Executive DirectorApril 9, 2024 | finance.yahoo.comArix Bioscience PLC (3HY.SG)April 25, 2024 | Prosper Trading Academy (Ad)These AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet.March 22, 2024 | msn.comLife sciences firm ReNeuron which received £13m in Welsh Government support enters administrationMarch 18, 2024 | seekingalpha.comAcacia Research: Positive Developments, Discount To Book Value High Despite Recent Price SpikeMarch 15, 2024 | finance.yahoo.comAcacia Research Corporation (NASDAQ:ACTG) Q4 2023 Earnings Call TranscriptFebruary 12, 2024 | markets.businessinsider.comSuspension of Trading in SharesJanuary 9, 2024 | finanznachrichten.deArix Bioscience PLC: Portfolio company Harpoon Therapeutics to be acquired by Merck (MSD)April 25, 2024 | Prosper Trading Academy (Ad)These AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet.January 8, 2024 | finanznachrichten.deArix Bioscience PLC: Portfolio company Harpoon Therapeutics to be -3-January 8, 2024 | finance.yahoo.comWith 40% ownership, Arix Bioscience plc (LON:ARIX) has piqued the interest of institutional investorsJanuary 5, 2024 | finanznachrichten.deArix Bioscience PLC: Publication of Circular and RTW Bio Prospectus -2-January 5, 2024 | markets.businessinsider.comPublication of Circular and RTW Bio ProspectusDecember 22, 2023 | finanznachrichten.deArix Bioscience PLC: Update regarding timing of Proposed Scheme of ReconstructionDecember 22, 2023 | markets.businessinsider.comUpdate regarding timing of Proposed Scheme of ReconstructionDecember 8, 2023 | markets.businessinsider.comPortfolio Company Aura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass TrialDecember 4, 2023 | thetimes.co.ukThorny case for Arix chief to answerNovember 19, 2023 | thetimes.co.ukArix Bioscience board’s Caribbean meeting left shareholders ‘flabbergasted’November 15, 2023 | finanznachrichten.deCorrection: Portfolio Company Aura Biosciences Announces Closing of USD99 million Public Offering of Common StockNovember 14, 2023 | finance.yahoo.comAcacia Research Corporation (NASDAQ:ACTG) Q3 2023 Earnings Call TranscriptNovember 14, 2023 | finance.yahoo.comQ3 2023 Acacia Research Corp Earnings CallNovember 13, 2023 | finance.yahoo.comAcacia Research Corp (ACTG) Reports Mixed Q3 Results Amid Strategic ShiftsNovember 12, 2023 | msn.comBroker Peel Hunt Ditches Arix Over Terms of Takeover DealNovember 10, 2023 | thetimes.co.ukBroker quits Arix over RTW takeoverNovember 9, 2023 | thetimes.co.ukDon’t swallow dog’s breakfast deal at Arix BioscienceNovember 5, 2023 | morningstar.comArix Bioscience PLC ARIXNovember 2, 2023 | thetimes.co.ukAmerican investment firm swoops for Arix BioscienceSee More Headlines Receive ARIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Arix Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:ARIX CUSIPN/A CIKN/A Webarixbioscience.com Phone+44-20-72901050FaxN/AEmployees9Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 0.11 Trailing P/E Ratio1,290.91 Forward P/E Ratio3.70 P/E GrowthN/ANet Income£14.96 million Net Margins105.64% Pretax MarginN/A Return on Equity6.41% Return on Assets2.18% Debt Debt-to-Equity Ratio0.01 Current Ratio73.10 Quick Ratio117.67 Sales & Book Value Annual Sales£14.16 million Price / Sales12.98 Cash FlowGBX 136.32 per share Price / Cash Flow1.04 Book ValueGBX 192 per share Price / Book0.74Miscellaneous Outstanding Shares129,390,000Free FloatN/AMarket Cap£183.73 million OptionableNot Optionable Beta1.05 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Tom DavidsonCOO & CFOMs. Laura CraigInvestor Relations OfficerDr. Tassos Konstantinou Ph.D.Managing DirectorMs. Jade FletcherFinancial ControllerMr. Felix Breyer Ph.D.AssociateMr. Roy Bartel-Taverner M.D.AnalystMore ExecutivesKey CompetitorshVIVOLON:HVOAvacta GroupLON:AVCTOxford BiomedicaLON:OXBCircassia GroupLON:CIRVerona Pharma plc (VRP.L)LON:VRPView All CompetitorsInsidersAndrew SmithBought 25,000 shares on 11/9/2023Total: £2.83 M ($113.00/share)Peregrine D E M MoncreiffeBought 60,000 shares on 11/2/2023Total: £6.90 M ($115.00/share)Debra BarkerBought 26,000 shares on 5/3/2023Total: £2.76 M ($106.00/share)View All Insider Transactions ARIX Stock Analysis - Frequently Asked Questions How have ARIX shares performed in 2024? Arix Bioscience's stock was trading at GBX 126 on January 1st, 2024. Since then, ARIX shares have increased by 12.7% and is now trading at GBX 142. View the best growth stocks for 2024 here. How do I buy shares of Arix Bioscience? Shares of ARIX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:ARIX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss RatingsFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arix Bioscience plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
